Biosensia

Biosensia developed RapiPlex, a point-of-care diagnosis system based on proprietary technologies capable of producing quantitative and qualitative laboratory quality test results.

Biosensia merged with Kypha in 2018, a USA based in-vitro diagnostics company, to co-develop immune and inflammation assays on the Biosensia point-of-care RapiPlex platform.

Jennifer Mcmahon

Managed by

Jennifer McMahon

Principal

We use cookies and analytics to improve your online experience and to help us to understand where our audience is and how they reach us, as well as to understand what topics and site features are of greatest interest.  To find out more, please read our Privacy Policy. By clicking on the Accept button, you consent to our use of cookies and browsing analytics.

Scroll to Top